← Apex Wire
Insider activity — UTHRUNITED THERAPEUTICS Corp

104 Form 4 filings for UTHR between 2026-07-09 and 2026-11-03, from 12 filers. 104 discretionary (1 sales, 93 purchases). 87 of 104 carry a dollar total (61 stated, 26 computed as shares × price), summing to $326,858,715; a multi-transaction filing without a stated total contributes only its largest transaction, so the sum is a floor and the true figure is higher. Prices ran $111 to $547.

Filings 104 Filers 12 Discretionary 104 Routine 0 Structured 52/104

Filers
▸ROTHBLATT MARTINE AChairperson & CEO 2026-11-03 · acquired (option exercise) 9,500 @ $117.76 for $5,664,136 TOTAL SOLD ≥ $1,056,425TOTAL BOUGHT ≥ $274,634,20610b5-1 ×8181 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-03 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,664,136 8 RECEIPT ↗
2026-11-02 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,700,856 14 RECEIPT ↗
2026-10-30 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,650,415 10 RECEIPT ↗
2026-10-29 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,562,190 7 RECEIPT ↗
2026-10-28 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,583,418 12 RECEIPT ↗
2026-10-27 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,592,095 9 RECEIPT ↗
2026-10-26 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,536,235 12 RECEIPT ↗
2026-10-23 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,542,094 22 RECEIPT ↗
2026-10-22 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,320,681 15 RECEIPT ↗
2026-10-21 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,261,741 18 RECEIPT ↗
2026-10-20 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,161,576 20 RECEIPT ↗
2026-10-19 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,079,275 14 RECEIPT ↗
2026-10-16 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,193,200 13 RECEIPT ↗
2026-10-15 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,129,873 17 RECEIPT ↗
2026-10-14 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,182,414 11 RECEIPT ↗
2026-10-13 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,231,666 8 RECEIPT ↗
2026-10-13 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,176,936 18 RECEIPT ↗
2026-10-09 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,075,919 17 RECEIPT ↗
2026-10-08 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,215,015 15 RECEIPT ↗
2026-10-07 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,117,412 18 RECEIPT ↗
2026-10-06 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,145,537 12 RECEIPT ↗
2026-10-05 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,219,015 24 RECEIPT ↗
2026-10-02 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $5,476,462 20 RECEIPT ↗
2026-10-01 sold 10b5-1 PLAN 400 $547.29 $1,056,425 8 RECEIPT ↗
2026-10-01 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $3,926,177 25 RECEIPT ↗
2026-09-30 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,535,480 13 RECEIPT ↗
2026-09-29 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,568,106 15 RECEIPT ↗
2026-09-28 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,523,635 10 RECEIPT ↗
2026-09-25 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,498,753 12 RECEIPT ↗
2026-09-24 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,669,918 13 RECEIPT ↗
2026-09-23 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,700,851 11 RECEIPT ↗
2026-09-22 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,698,271 6 RECEIPT ↗
2026-09-21 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,700,505 7 RECEIPT ↗
2026-09-18 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,712,580 10 RECEIPT ↗
2026-09-17 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,763,172 9 RECEIPT ↗
2026-09-16 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,765,119 7 RECEIPT ↗
2026-09-15 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,789,152 6 RECEIPT ↗
2026-09-14 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,757,773 13 RECEIPT ↗
2026-09-11 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,772,295 11 RECEIPT ↗
2026-09-10 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,767,467 15 RECEIPT ↗
2026-09-09 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,740,795 16 RECEIPT ↗
2026-09-08 acquired (option exercise) 10b5-1 PLAN 9,500 $117.76 $4,647,354 8 RECEIPT ↗
2026-09-04 acquired (option exercise) 10b5-1 PLAN 8,910 $135.42 $4,631,619 14 RECEIPT ↗
2026-09-02 acquired (option exercise) 10b5-1 PLAN 9,500 $135.42 $4,883,839 8 RECEIPT ↗
2026-09-01 acquired (option exercise) 10b5-1 PLAN 9,500 $135.42 $4,855,312 9 RECEIPT ↗
2026-08-31 acquired (option exercise) 10b5-1 PLAN 9,500 $135.42 $4,916,363 12 RECEIPT ↗
2026-08-28 acquired (option exercise) 10b5-1 PLAN 9,500 $135.42 $4,964,376 19 RECEIPT ↗
2026-08-27 acquired (option exercise) 10b5-1 PLAN 9,500 $135.42 $4,914,190 9 RECEIPT ↗
2026-08-26 acquired 10b5-1 PLAN 9,500 $135.42 $4,918,273 7 RECEIPT ↗
2026-08-25 acquired 10b5-1 PLAN 9,500 $135.42 $4,863,730 6 RECEIPT ↗
2026-08-24 acquired 10b5-1 PLAN 9,500 $135.42 $4,924,666 16 RECEIPT ↗
2026-08-21 acquired 10b5-1 PLAN 9,500 $135.42 $4,949,717 9 RECEIPT ↗
2026-08-20 acquired 10b5-1 PLAN 9,500 $135.42 $5,006,104 13 RECEIPT ↗
2026-08-19 acquired 10b5-1 PLAN 9,500 $135.42 $4,898,221 11 RECEIPT ↗
2026-08-18 acquired 10b5-1 PLAN 9,500 $135.42 $4,812,568 8 RECEIPT ↗
2026-08-17 acquired 10b5-1 PLAN 9,500 $135.42 $4,739,664 8 RECEIPT ↗
2026-08-14 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 13 RECEIPT ↗
2026-08-13 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 15 RECEIPT ↗
2026-08-12 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 17 RECEIPT ↗
2026-08-11 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 15 RECEIPT ↗
2026-08-10 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 16 RECEIPT ↗
2026-08-07 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 19 RECEIPT ↗
2026-08-06 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 17 RECEIPT ↗
2026-08-05 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 10 RECEIPT ↗
2026-08-04 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 6 RECEIPT ↗
2026-08-03 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 10 RECEIPT ↗
2026-07-30 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 9 RECEIPT ↗
2026-07-28 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 11 RECEIPT ↗
2026-07-27 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 10 RECEIPT ↗
2026-07-27 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 8 RECEIPT ↗
2026-07-24 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 11 RECEIPT ↗
2026-07-23 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 15 RECEIPT ↗
2026-07-22 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 12 RECEIPT ↗
2026-07-21 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 9 RECEIPT ↗
2026-07-20 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 12 RECEIPT ↗
2026-07-17 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 11 RECEIPT ↗
2026-07-15 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 10 RECEIPT ↗
2026-07-14 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 10 RECEIPT ↗
2026-07-13 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 11 RECEIPT ↗
2026-07-09 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 9 —
2026-07-09 acquired 10b5-1 PLAN 9,500 $135.42 ≥ $1,286,490 13 —
▸MAHON PAUL AEVP & GENERAL COUNSEL 2026-10-16 · acquired (option exercise) 8,300 @ $146.03 for $4,517,709 TOTAL BOUGHT ≥ $17,678,44710b5-1 ×55 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-10-16 acquired (option exercise) 10b5-1 PLAN 8,300 $146.03 $4,517,709 7 RECEIPT ↗
2026-10-01 acquired (option exercise) 10b5-1 PLAN 8,300 $146.03 $4,689,051 11 RECEIPT ↗
2026-09-18 acquired (option exercise) 10b5-1 PLAN 8,300 $146.03 $4,129,608 8 RECEIPT ↗
2026-08-21 acquired 10b5-1 PLAN 5,610 $146.03 $4,342,079 11 RECEIPT ↗
2026-08-06 acquired 10b5-1 PLAN 8,300 $146.03 ≥ $1,212,049 9 RECEIPT ↗
▸Mesa NildaDirector 2026-09-15 · acquired (option exercise) 130 @ $110.86 for $115,338 TOTAL BOUGHT ≥ $115,3383 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-09-15 acquired (option exercise) 130 $110.86 $115,338 3 RECEIPT ↗
2026-07-23Mesa Nilda (Director at UNITED THERAPEUTICS Corp) filed a Form 4; no parseable transaction details were found in the filing.RECEIPT ↗
2026-07-13 acquired 650 — — — RECEIPT ↗
▸DZAU VICTOR Jrole unstated 2026-07-23 1 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-07-23DZAU VICTOR J (Director at UNITED THERAPEUTICS Corp) filed a Form 4; no parseable transaction details were found in the filing.RECEIPT ↗
▸MAXWELL LINDArole unstated 2026-07-23 1 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-07-23MAXWELL LINDA (Director at UNITED THERAPEUTICS Corp) filed a Form 4; no parseable transaction details were found in the filing.RECEIPT ↗
▸Tracey Kevinrole unstated 2026-07-23 1 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-07-23Tracey Kevin (Director at UNITED THERAPEUTICS Corp) filed a Form 4; no parseable transaction details were found in the filing.RECEIPT ↗
▸Olian Judy D.role unstated 2026-07-23 2 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-07-23Olian Judy D. (Director at UNITED THERAPEUTICS Corp) filed a Form 4; no parseable transaction details were found in the filing.RECEIPT ↗
2026-07-13 acquired 1,310 — — — RECEIPT ↗
▸MALCOLM JANrole unstated 2026-07-23 10b5-1 ×22 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-07-23MALCOLM JAN (Director at UNITED THERAPEUTICS Corp) filed a Form 4; no parseable transaction details were found in the filing.RECEIPT ↗
2026-07-10 acquired 10b5-1 PLAN 650 — — 2 —
▸SULLIVAN LOUIS Wrole unstated 2026-07-23 2 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-07-23SULLIVAN LOUIS W (Director at UNITED THERAPEUTICS Corp) filed a Form 4; no parseable transaction details were found in the filing.RECEIPT ↗
2026-07-13 acquired 650 — — — RECEIPT ↗
▸PATUSKY CHRISTOPHERrole unstated 2026-07-23 2 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-07-23PATUSKY CHRISTOPHER (Director at UNITED THERAPEUTICS Corp) filed a Form 4; no parseable transaction details were found in the filing.RECEIPT ↗
2026-07-13 acquired 650 — — — RECEIPT ↗
▸Giltner Richardrole unstated 2026-07-23 2 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-07-23Giltner Richard (Director at UNITED THERAPEUTICS Corp) filed a Form 4; no parseable transaction details were found in the filing.RECEIPT ↗
2026-07-13 acquired 1,310 — — — RECEIPT ↗
▸KURZWEIL RAYrole unstated 2026-07-23 2 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-07-23KURZWEIL RAY (Director at UNITED THERAPEUTICS Corp) filed a Form 4; no parseable transaction details were found in the filing.RECEIPT ↗
2026-07-13 acquired 650 — — — RECEIPT ↗

12 filers · 104 filings · disclosed filing totals sum to $326,858,715 (61/104 state one, 26 computed; totals are proceeds with a floor, never profit — a Form 4 states what was traded, not what it cost the filer)

Elsewhere